Back to School: How biopharma can reboot drug development. Access exclusive analysis here
ZNXS and Secretech Inc. reached an agreement in principle to merge the Birmingham, Ala., company with ZNXS for 3 million shares of
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury